DE3880498D1 - Verwendung von 5-aminosalicylsaeure (5-asa) zur herstellung einer arzneimittelzubereitung zur verwendung bei einer reperfusionsbehandlung. - Google Patents

Verwendung von 5-aminosalicylsaeure (5-asa) zur herstellung einer arzneimittelzubereitung zur verwendung bei einer reperfusionsbehandlung.

Info

Publication number
DE3880498D1
DE3880498D1 DE8888909305T DE3880498T DE3880498D1 DE 3880498 D1 DE3880498 D1 DE 3880498D1 DE 8888909305 T DE8888909305 T DE 8888909305T DE 3880498 T DE3880498 T DE 3880498T DE 3880498 D1 DE3880498 D1 DE 3880498D1
Authority
DE
Germany
Prior art keywords
treatment
asa
coronary
producing
medicinal preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888909305T
Other languages
English (en)
Other versions
DE3880498T2 (de
Inventor
Stig Bondesen
Soren Halskov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmaceutisk Laboratorium Ferring AS
Original Assignee
Farmaceutisk Laboratorium Ferring AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutisk Laboratorium Ferring AS filed Critical Farmaceutisk Laboratorium Ferring AS
Publication of DE3880498D1 publication Critical patent/DE3880498D1/de
Application granted granted Critical
Publication of DE3880498T2 publication Critical patent/DE3880498T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8888909305T 1987-10-14 1988-10-13 Verwendung von 5-aminosalicylsaeure (5-asa) zur herstellung einer arzneimittelzubereitung zur verwendung bei einer reperfusionsbehandlung. Expired - Fee Related DE3880498T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK536987A DK536987A (da) 1987-10-14 1987-10-14 Anvendelse af 5-aminosalicylsyre (5-asa) til fremstilling af et farmaceutisk praeparat til anvendelse ved reperfusionsbehandling
PCT/DK1988/000166 WO1989003216A1 (en) 1987-10-14 1988-10-13 Use of 5-aminosalicyclic acid (5-asa) for the production of a pharmaceutical preparation for use in reperfusion treatment

Publications (2)

Publication Number Publication Date
DE3880498D1 true DE3880498D1 (de) 1993-05-27
DE3880498T2 DE3880498T2 (de) 1993-09-23

Family

ID=8141887

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888909305T Expired - Fee Related DE3880498T2 (de) 1987-10-14 1988-10-13 Verwendung von 5-aminosalicylsaeure (5-asa) zur herstellung einer arzneimittelzubereitung zur verwendung bei einer reperfusionsbehandlung.

Country Status (7)

Country Link
EP (1) EP0387265B1 (de)
JP (1) JPH03503161A (de)
KR (1) KR890701110A (de)
AT (1) ATE88345T1 (de)
DE (1) DE3880498T2 (de)
DK (1) DK536987A (de)
WO (1) WO1989003216A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010069A (en) * 1989-05-15 1991-04-23 Marion Laboratories, Inc. Stable liquid form of 5-aminosalicylic acid
AU668682B2 (en) * 1991-02-22 1996-05-16 Howard K. Shapiro Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration

Also Published As

Publication number Publication date
JPH03503161A (ja) 1991-07-18
WO1989003216A1 (en) 1989-04-20
DE3880498T2 (de) 1993-09-23
ATE88345T1 (de) 1993-05-15
KR890701110A (ko) 1989-12-19
EP0387265A1 (de) 1990-09-19
EP0387265B1 (de) 1993-04-21
DK536987D0 (da) 1987-10-14
DK536987A (da) 1989-04-15

Similar Documents

Publication Publication Date Title
AU1321688A (en) Method and composition for the treatment and prevention of viral infections
IT8748330A0 (it) Copolimero promotore del rilascio di sudiciume,procedimento di produzione e composizione detergente contenente detto copolimero
NO942468L (no) Fremgangsmåte for fremstilling av 2-alkyl-3,4,6-trifluorbenzoesyre
FI931097A0 (fi) Laekemedel, deras framstaellning och anvaendning vid bekaempning av smaertor och/eller inflammationen hos maenniskor och djur
DE69115765D1 (de) Herstellung von optisch aktiven arylaliphatischen Carbonsäuren
DE69331465D1 (de) Intravenöse lösung, die den protein - und wasserverlust im körper reduziert
DE3880498D1 (de) Verwendung von 5-aminosalicylsaeure (5-asa) zur herstellung einer arzneimittelzubereitung zur verwendung bei einer reperfusionsbehandlung.
ATE15186T1 (de) Halogenbenzhydrylsulfinylacethydroxamsaeure, ihre herstellung sowie pharmazeutische mittel.
HUT59600A (en) Process for producing pharmaceutical compositions containing 5-methyl-isoxazoe-4-carboxylik-anilides or alpha-/2-hydroxy-ethylidene/-alpha-cyano-acetic-anilides for treating eye-diseases
SE8803125D0 (sv) Orala magnesium- och kaliumkompositioner
KR960014789B1 (en) Composition of human blood coagulation factor ñ˜ñ for thr treatment of ulcerative colitis
DK0420368T3 (da) Kombinationsprodukt med antithrombotisk virkning
NO924637L (no) Fremgangsmaate ved forhindring av gjentilstopping av arterier
DE69231098D1 (de) Lyophilisierte zusammensetzung, die s(+)-4,4'-(1-methyl-1,2-ethandiyl)-bis(2,6-piperazindion)enthält
CA985702A (en) Polymers of 1-butene-2,3,4-tricarboxylic acid and their use as detergent builders
MX9207343A (es) Derivados antitromboticos de acido diaminoalcanoico.
Grishina et al. Immunotyping of newly isolated Pseudomonas aeruginosa strains.
RO100495A2 (ro) Procedeu de preparare a sarii de magneziu a acidului ascorbic-solutie 10%
Oana et al. Actual epidemiological aspect of streptococcal infection.
JPS5347391A (en) Titanium oxide moldings for fluidized-bed catalysts
FR1288021A (fr) Procédé de préparation d'esters de nouveaux halogéno-prégnanes, notamment de delta4-3, 20-dicéto-6alpha-fluoro-ones de delta4-3, 20-dicéto-6alpha-méthyl-17alpha,21-dihydroxy-prégnènes, de composés correspondants ayant une double liaison en position 1, 2 et de 21-acyloxy composés
TH5595EX (th) คานอาคาร
IT8704728V0 (it) Scaffalatura di fabbricazione industriale,razionale,multiuso e con grandi possibilita'espositive di composizione e trasformazione
FR1432061A (fr) Procédé pour la fabrication de compositions sèches pour la préparation de flans,susceptibles d'être formées en dés, ou en corps de forme analogue, et compositionpour flans ainsi obtenue
TH4888EX (th) ขวด

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee